Literature DB >> 8422702

Rapid effects of EGF on cytoskeletal structures and adhesive properties of highly metastatic rat mammary adenocarcinoma cells.

R B Lichtner1, M Wiedemuth, C Noeske-Jungblut, V Schirrmacher.   

Abstract

In the highly metastatic rat mammary adenocarcinoma cell clone MTLn3, EGF induced increased adhesion to fibronectin while in the human epidermoid carcinoma cell line A431 EGF induced diminished adhesive properties. Flattening of cells with extensive formation of filopodia was observed in MTLn3 cells within 5 min of EGF addition, while in A431 cells EGF induced rounding up and only occasional formation of filopodia. Immunofluorescent analysis revealed extension of microtubules (MT) into the filopodia and Western blot analysis demonstrated an EGF-induced 2- to 3-fold increase in the amount of assembled tubulin in MTLn3 but not in A431 cells. In MTLn3, but only marginally in A431 cells, EGF treatment resulted in phosphorylation of a 280 kD cytoskeleton-associated protein, which was rapid and dose-dependent. These results suggest differential signal transduction pathway of cytoskeleton-associated EGFRs in highly metastatic MTLn3 as compared with A431 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422702     DOI: 10.1007/bf00880072

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  60 in total

1.  Increased adhesion of Chinese hamster ovary cells to substratum by cholera enterotoxin.

Authors:  R Nozawa; F Kon; T Yokota; M Ohashi; S Kuwahara
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

Review 2.  Growth factors in the regulation of pericellular proteolysis: a review.

Authors:  M Laiho; J Keski-Oja
Journal:  Cancer Res       Date:  1989-05-15       Impact factor: 12.701

3.  Fibronectin: purification, immunochemical properties, and biological activities.

Authors:  E Ruoslahti; E G Hayman; M Pierschbacher; E Engvall
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

4.  Direct effects of the pyrimido-pyrimidine derivative RA 233 (Rapenton) on rat 13762NF mammary tumor cell clones in vitro.

Authors:  R B Lichtner; T J Goka; R W Butcher; G L Nicolson
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

5.  Effects of the pyrimido-pyrimidine derivative RX-RA 85 on metastatic tumor cell-vascular endothelial cell interactions.

Authors:  R B Lichtner; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

Review 6.  'Seed and soil' revisited: mechanisms of site-specific metastasis.

Authors:  I R Hart
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro.

Authors:  L B Ray; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.

Authors:  G L Nicolson; I J Fidler; G Poste
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

9.  Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture.

Authors:  D W Barnes
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

10.  Differential effects of epidermal growth factor (EGF) on cell locomotion and cell proliferation in a cloned human embryonal carcinoma-derived cell line in vitro.

Authors:  W Engström
Journal:  J Cell Sci       Date:  1986-12       Impact factor: 5.285

View more
  10 in total

1.  Optogenetic engineering: light-directed cell motility.

Authors:  Robert M Hughes; David S Lawrence
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-25       Impact factor: 15.336

Review 2.  New treatments for bladder cancer: when will we make progress?

Authors:  Rosa Nadal; Joaquim Bellmunt
Journal:  Curr Treat Options Oncol       Date:  2014-03

3.  Design, construction, and validation of optogenetic proteins.

Authors:  Colin P O'Banion; Anwesha Goswami; David S Lawrence
Journal:  Methods Enzymol       Date:  2019-03-12       Impact factor: 1.600

4.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

5.  Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.

Authors:  M Zhang; R K Singh; M H Wang; A Wells; G P Siegal
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

6.  Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase.

Authors:  M A Adelsman; J B McCarthy; Y Shimizu
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

7.  Characterization of mechanical behavior of an epithelial monolayer in response to epidermal growth factor stimulation.

Authors:  Ruiguo Yang; Jennifer Y Chen; Ning Xi; King Wai Chiu Lai; Chengeng Qu; Carmen Kar Man Fung; Lynn S Penn; Jun Xi
Journal:  Exp Cell Res       Date:  2011-12-29       Impact factor: 3.905

Review 8.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

9.  In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.

Authors:  H Xie; T Turner; M H Wang; R K Singh; G P Siegal; A Wells
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

Review 10.  EGF receptor expression, regulation, and function in breast cancer.

Authors:  S A Chrysogelos; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.